
SMARCA2 - Wikipedia
Probable global transcription activator SNF2L2 is a protein that in humans is encoded by the SMARCA2 gene. [5] [6]
SMARCA2 Gene - GeneCards | SMCA2 Protein | SMCA2 Antibody
Dec 25, 2024 · Complete information for SMARCA2 gene (Protein Coding), SWI/SNF Related BAF Chromatin Remodeling Complex Subunit ATPase 2, including: function, proteins, …
Herein, we present development of a potent and selective SMARCA2 degrader, structurally unrelated to known chemotypes with first in class potential selectively targeting SMARCA4 …
Selective PROTAC-mediated degradation of SMARCA2 is ... - Nature
Nov 10, 2022 · Selective SMARCA2 degradation is achieved in the absence of selective SMARCA2/4 PROTAC binding and translates to potent in vitro growth inhibition and in vivo …
SMARCA2 - an overview | ScienceDirect Topics
SMARCA2 has been identified as a key synthetic lethal target in SMARCA4-deficient cancers, yet the mechanism underlying the synthetic lethal relationship is unclear.
SMARCA2 gene - MedlinePlus
The SMARCA2 gene provides instructions for making one piece (subunit) of a group of similar protein complexes known as SWI/SNF complexes. These complexes regulate gene activity …
SMARCA2 protein: Structure, function and perspectives of drug …
5 days ago · SMARCA2 is an ATPase that regulates chromatin structure via ATP pathways, controlling cell division and differentiation. SMARCA2's bromodomain and ATPase domain, …
SMARCA2 (BRM) Molecule Overview | Lilly Oncology
BAF requires either SMARCA2 (BRM) or SMARCA4 (BRG1), mutually exclusive ATPase subunits, for chromatin remodeling to occur. Inhibiting SMARCA2 in SMARCA4-deficient …
SMARCA2 - Prelude Therapeutics
Using the TPD approach, Prelude is developing highly potent and selective SMARCA2 protein degraders designed to specifically inhibit SMARCA4-deficient tumors.
• Selective SMARCA2 degradation modulates gene expression via transcriptional regulation in sensitive cell lines, enabling the identification of robust biomarkers